Most Recent
Bauer’s appeal victory means curtain call for Discover Downunder trade mark
Intellectual Property May 9, 2019 4:08 pm By Miklos Bolza

Bauer Consumer Media has won a five-year legal battle over Evergreen Television’s Discover Downunder trade mark, with the Full Federal Court setting aside a prior […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
After drawing scrutiny from judge, toxic foam class action funding structure revealed
Product Liability April 23, 2019 10:41 pm By Christine Caulfield

The sought-after commission at the centre of an unsuccessful common fund application in a class action over the use of toxic foam at a RAAF […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Common fund bid in toxic foam class action dismissed after applicant bristles at more scrutiny
Class Actions April 12, 2019 11:36 pm By Christine Caulfield

A judge has tossed an application for a common fund order in a class action over the use of toxic foam on a RAAF base […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Generics attack validity of Neurim insomnia drug patent
Intellectual Property April 5, 2019 8:28 pm By Miklos Bolza

Two generic pharmaceutical companies, Generic Partners and Apotex, have filed cross-claims alleging that Neurim Pharmaceuticals’ patent for its insomnia drug Circadin is invalid and should […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Judge ‘uncomfortable’ with common fund order in toxic foam class actions
Class Actions April 3, 2019 5:21 pm By Miklos Bolza

A judge overseeing three toxic foam class actions against the Commonwealth of Australia has said he’s not comfortable approving a common fund order which does […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Toxic foam class action not time-barred, court hears
Class Actions January 10, 2019 10:36 pm By Cat Fredenburgh

The applicants in a class action¬†over exposure to allegedly toxic foam used on a government military base have struck back at the Commonwealth of Australia’s […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
MFS execs lose appeal over $147.5M in misused funds
Financial Services December 18, 2018 5:56 pm By Miklos Bolza

Three former executives of failed Gold Coast finance company MFS Group have lost their challenge to a ruling that they misappropriated $147.5 million in funds […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
ASIC asks High Court to clarify meaning of ‘officer’
Corporate January 16, 2019 9:58 pm By Miklos Bolza

ASIC is seeking approval from the High Court to appeal a judgment that let a former director of Gold Coast finance company MFS Group partially […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Neurim wins fight to amend patent for top-selling Circadin amid infringement case
Intellectual Property February 19, 2019 7:35 pm By Christine Caulfield

Drug maker Neurim Pharmaceuticals has won a bid to amend its Australian patent for top selling sleeping pill Circadin over the protests of two generic […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Neurim fights to amend Circadin patent amid infringement case against generics
Intellectual Property November 12, 2018 9:19 pm By Miklos Bolza

Drug maker Neurim Pharmaceuticals is battling to amend its Australian patent for the blockbuster sleeping pill Circadin over opposition from two generic pharmaceutical companies, which […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.